1. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2, Suppl):e227S-77S. PMID: 22315263. http://dx.doi.org10.1378/chest.11-2297.

2. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3, Suppl):338S-400S. PMid:15383478. http://dx.doi.org/10.1378/chest.126.3_suppl.338S.

3. Simone EP, Madan AK, Tichansky DS, Kuhl DA, Lee MD. Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery. Surg Endosc. 2008;22(11):2392-5. PMid:18594915. http://dx.doi.org/10.1007/s00464-008-9997-6.

4. Hamad GG, Choban PS. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Obes Surg. 2005;15(10):1368-74. PMid:16354513. http://dx.doi.org/10.1381/096089205774859 245.

5. Sapala JA, Wood MH, Schuhknecht MP, Sapala MA. Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg. 2003;13(6):819-25. PMid:14738663. http://dx.doi.org/10.1381/096089203322618588.

6. Gonzalez QH, Tishler DS, Plata-Munoz JJ, et al. Incidence of clinically evident deep venous thrombosis after laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2004;18(7):1082-4. PMid:15156394. http://dx.doi.org/10.1007/s00464-003-8202-1.

7. Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232(4):515-29. PMid:10998650. http://dx.doi.org/10.1097/00000658-200010000-00007.

8. Melinek J, Livingston E, Cortina G, Fishbein MC. Autopsy findings following gastric bypass surgery for morbid obesity. Arch Pathol Lab Med. 2002;126(9):1091-5. PMid:12204059.

9. Bajardi G, Ricevuto G, Mastrandrea G, et al. Postoperative venous thromboembolism in bariatric surgery. Minerva Chir. 1993;48(10):539-42. PMid:8367068.

10. Fobi MA, Lee H, Holness R, Cabinda D. Gastric bypass operation for obesity. World J Surg. 1998;22(9):925-35. PMid:9717418. http://dx.doi.org/10.1007/s002689900496.

11. Becattini C, Agnelli G, Manina G, Noya G, Rondelli F. Venous thromboembolism after laparoscopic bariatric surgery for morbid obesity: clinical burden and prevention. Surg Obes Relat Dis. 2012;8(1):108-15. PMid:22014482. http://dx.doi.org/10.1016/j.soard.2011.09.005.

12. Ojo P, Asiyanbola B, Valin E, Reinhold R. Post discharge prophylactic anticoagulation in gastric bypass patient-how safe? Obes Surg. 2008;18(7):791-6. PMid:18386108. http://dx.doi.org/10.1007/s11695-007-9382-x.

13. Stroh C, Michel N, Luderer D, et al. Risk of thrombosis and thromboembolic prophylaxis in obesity surgery: data analysis from the German Bariatric Surgery Registry. Obes Surg. 2016;26(11):2562-71. PMid:27112588. http://dx.doi.org/10.1007/s11695-016-2182-4.

14. Frezza EE, Chiriva-Internati M. Venous thromboembolism in morbid obesity and trauma. A review of literature. Minerva Chir. 2005;60(5):391-9. PMid:16210988.

15. Cotter SA, Cantrell W, Fisher B, Shopnick R. Efficacy of venous thromboembolism prophylaxis in morbidly obese patients undergoing gastric bypass surgery. Obes Surg. 2005;15(9):1316-20. PMid:16259895. http://dx.doi.org/10.1381/096089205774512690.

16. Steele KE, Canner J, Prokopowicz G, et al. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial. Surg Obes Relat Dis. 2015;11(3):672-83. PMid:25620436. http://dx.doi.org/10.1016/j.soard.2014.10.003.

17. Vandiver JW, Ritz LI, Lalama JT. Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendations. J Thromb Thrombolysis. 2016;41(3):475-81. PMid:25982217. http://dx.doi.org/10.1007/s11239-015-1231-5.

18. Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg. 2002;12(1):19-24. PMid:11868291. http://dx.doi.org/10.1381/096089202321144522.

19. Borkgren-Okonek MJ, Hart RW, Pantano JE, et al. Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity. Surg Obes Relat Dis. 2008;4(5):625-31. PMid:18261965. http://dx.doi.org/10.1016/j.soard.2007.11.010.

20. Wang TF, Milligan PE, Wong CA, Deal EN, Thoelke MS, Gage BF. Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients. Thromb Haemost. 2014;111(1):88-93. PMid:24136071. http://dx.doi.org/10.1160/TH13-01-0042.

21. Yoshida RA, Yoshida WB. Profilaxia do tromboembolismo venoso em pacientes cirúrgicos. In: Maffei FHA, editor. Doenças vasculares periféricas. Rio de Janeiro: GEN; 2015. v. 2, p. 1916-1923